Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) closed the day trading at $1.78 down -7.77% from the previous closing price of $1.93. In other words, the price has decreased by -$7.77 from its previous closing price. On the day, 2.38 million shares were traded.
Ratios:
For a better understanding of SLS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 4.64. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 22 ’25 when Kalin Katherine Bach bought 20,000 shares for $1.80 per share. The transaction valued at 36,000 led to the insider holds 41,000 shares of the business.
Stock Price History:
Over the past 52 weeks, SLS has reached a high of $2.12, while it has fallen to a 52-week low of $0.77. The 50-Day Moving Average of the stock is 27.76%, while the 200-Day Moving Average is calculated to be 43.65%.
Shares Statistics:
A total of 99.78M shares are outstanding, with a floating share count of 97.68M. Insiders hold about 2.10% of the company’s shares, while institutions hold 14.33% stake in the company.
